A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia

Completed · Phase 3 · Has a placebo group

Conditions studied: Severe Hypertriglyceridemia

In brief

The purpose of the study is to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from baseline.

Key facts

Study ID
NCT05079919
Run by
Ionis Pharmaceuticals, Inc.
People needed
617
Starts
2021-10-25
Expected to finish
2025-07-08
Last updated by the study team
2026-02-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.